Events

We welcome you to the 3rd Congress of the International Society of Nutrigenetics/Nutrigenomics (ISNN), cosponsored by the Division of Cancer Prevention of the National Cancer Institute; the Center for Genetics, Nutrition and Health in Washington, DC; and several groups within the U.S Department of Health and Human Services and the...
This third Translational Research in Paediatric Rheumatology conference will showcase the growing body of evidence that the regulation of central and peripheral B and T cell development plays a pivotal role in the pathogenesis of autoimmune diseases, highlighting the molecular and cellular mechanisms involved in the activation of the effector...
EPPOSI is pleased to announce that its 10th Workshop on Partnering for Rare Disease Therapy Development will be hosted by the Belgian Federal Parliament on Monday 26 – Tuesday 27 October 2009 in Brussels. The event will be co-chaired by Mr. Yann Le Cam (EURORDIS), Pr. Jean-Jacques Cassiman (ESHG), Dr....
1) Disseminate current knowledge of the standard treatment of hairy cell leukemia (HCL), 2) Identify the evidence (or lack thereof) with which current treatment practices are based, 3) determine needs and opportunities for clinical research to improve HCL treatment, 4) disseminate results of newer diagnostic techniques, including flow cytometry, PCR...
The goals of this workshop are to (1) obtain an update on recent developments in the fields of basic immunology, immune responses to neglected tropical disease (NTD)-causing agents, and pathogenic mechanisms of NTDs; (2) determine what are the knowledge gaps and under-emphasized research areas for certain diseases that may not...
The goals of this conference are to (1) facilitate international discussion and team-building of hematopoietic cell transplant physicians and autoimmune disease experts to work together for treatment of patients with autoimmune diseases, (2) focus on the aspects of HCT therapy that are particularly challenging for autoimmune diseases, (3) identify questions...
This workshop will provide an important forum for bringing together NIH researchers from across the Institutes and Centers with representatives from the Food and Drug Administration (FDA) as well as professional societies and patient advocates to explore the potential utility of adaptive designs. Additional Information: Conference Web Site
Workshop participants will identify gaps in knowledge, prioritize basic and clinical research questions, identify existing resources that can be applied to Prader-Willi syndrome (PWS) research, identify needed resources and technologies, establish cross-disciplinary and multidisciplinary collaboration, formulate a framework for advancing PWS research, and provide a published report of a comprehensive...
This new meeting (International Conference on Sarcoma Biology) will interface with the Milan translational sarcoma meeting, in that the Milan meeting organizers will provide feedback on the proposed programs, and they will participate (as attendees) in the sarcoma biology meeting. The aim of the International Conference on Sarcoma Biology is...
Several of the symposia and/or individual presentations within the symposia are expected to be published in the refereed literature, especially in Environmental Molecular Mutagenesis or Mutation Research. In additions, the interactions among the numerous highly experienced researchers who will attend this meeting are expected to generate collaborations that will substantially...
The goals of the Working Group are to identify research priorities for translational II research in sickle cell disease. The Working Group is designed to foster cross-disciplinary communication and to ensure that other disciplines and skill sets are included in sickle cell research. These priorities—the study designs, methods, disciplines, and...
The conference in 2009 will be the first opportunity to present and discuss results from the initial TSC clinical trials and additional data from basic research and to discuss plans for new clinical trials utilizing mTOR inhibitors and other drug targets. There are significant research opportunities to be discussed and...
Conference goals are to (a) provide a better awareness and harmonization of the diagnostic criteria of the disease and cofactors that contribute to the evolution of clinical disease associated with the defined genetic defects of autoimmune lymphoproliferative syndrome (ALPS) in the hematology, oncology, immunology, and infectious disease community; (b) establish...